Inventor · disambiguated record
David R. Hill
Also filed as: HILL DAVID R · HILL DAVID ROBERT
13 granted patents·8 pending applications·257 citations·filing 1995–2019
91Inventor score
Top patents by PatentIndex Score
21 records- 0195US6437106B1Process for preparing 6-o-substituted erythromycin derivativesABBOTT LAB·Filed 2000·Granted Aug 20, 2002·161 cites·30 claims
- 0294US9809534B1Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereofABBVIE INC·Filed 2015·Granted Nov 7, 2017·8 cites·15 claims
- 0393US9809576B1Synthetic route to anti-viral agentsABBVIE INC·Filed 2015·Granted Nov 7, 2017·14 cites·2 claims
- 0489US8168784B2Processes to make apoptosis promotersFRANCZYK II THADDEUS STEPHAN·Filed 2009·Granted May 1, 2012·31 cites·10 claims
- 0586US10077256B2Synthetic route to anti-viral agentsABBVIE INC·Filed 2017·Granted Sep 18, 2018·2 cites·14 claims
- 0680US10316338B1Enzymatic process for the preparation of (1S,2R)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic acidABBVIE INC·Filed 2016·Granted Jun 11, 2019·2 cites·13 claims
- 0773US2020095230A1Synthetic route to anti-viral agentsABBVIE INC·Filed 2019·Application pending·0 cites
- 0872US2020115329A1Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereofABBVIE INC·Filed 2019·Application pending·0 cites
- 0970US10442792B2Synthetic route to anti-viral agentsABBVIE INC·Filed 2018·Granted Oct 15, 2019·0 cites·30 claims
- 1069US10421712B2Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereofABBVIE INC·Filed 2017·Granted Sep 24, 2019·0 cites·18 claims
- 1169US6350902B2Process for the selective N-formylation of N-hydroxylaminesABBOTT LAB·Filed 2001·Granted Feb 26, 2002·5 cites·11 claims
- 1269US5929219A9-hydrazone and 9-azine erythromycin derivatives and a process of making the sameABBOTT LAB·Filed 1997·Granted Jul 27, 1999·23 cites·14 claims
- 1360US5760216AUse of synthetic metalloporphyrins for preparation and prediction of drug metabolitesABBOTT LAB·Filed 1995·Granted Jun 2, 1998·10 cites·7 claims
- 1458USRE39531E9-hydrazone and 9-azine erythromycin derivatives and a process for making the sameABBOTT LAB·Filed 2004·Granted Mar 27, 2007·0 cites·24 claims
- 1557US2020024621A1Enzymatic process for the preparation of (1s,2r)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic acidABBVIE INC·Filed 2019·Application pending·0 cites
- 1652US6441189B1Process for the preparation of matrix metalloproteinase inhibitorsABBOTT LAB·Filed 2001·Granted Aug 27, 2002·1 cites·4 claims
- 1737US2002019539A1Process for the preparation of matrix metalloproteinase inhibitorsFiled 2001·Application pending·0 cites
- 1837US2003055297A1Process for the preparation of substituted pyrrolidine neuraminidase inhibitorsFiled 2002·Application pending·0 cites
- 1936US2009029984A1Synergistic combination for the treatment of pain (cannabinoid receptor agonist and opioid receptor agonist)ORGANON NV·Filed 2006·Application pending·0 cites
- 2035US2002128496A1Process for the preparation of matrix metalloproteinase inhibitorsFiled 2002·Application pending·0 cites
- 2135US2001031896A1Process for the selective N-formylation of N-hydroxylaminesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David R. Hill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →